Cartesian Therapeutics, Inc. (NASDAQ:RNAC) currently has 8 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 30 Sep, 2025 | 2,155,783 | -178,341 | -7.64% | $22,032,103.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 649,341 | -4,499 | -0.69% | $6,636,266.00 |
| Siren, L.L.C. | 30 Sep, 2025 | 563,272 | 0 | 0.00% | $5,756,640.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 520,722 | 24,356 | 4.91% | $5,321,779.00 |
| MPM BioImpact LLC | 30 Sep, 2025 | 380,000 | -306,007 | -44.61% | $3,883,600.00 |
| Erste Asset Management GmbH | 30 Sep, 2025 | 260,011 | 0 | 0.00% | $2,561,108.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 241,829 | 22,902 | 10.46% | $2,471,880.00 |
| 683 Capital Management, LLC | 30 Sep, 2025 | 230,000 | 11,000 | 5.02% | $2,350,601.00 |
| STATE STREET CORP | 30 Sep, 2025 | 197,666 | 3,397 | 1.75% | $2,020,147.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 91,289 | 8,345 | 10.06% | $932,974.00 |
| GSA CAPITAL PARTNERS LLP | 30 Sep, 2025 | 86,095 | 44,493 | 106.95% | $880.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 84,806 | 2,176 | 2.63% | $866,718.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 70,524 | 70,524 | 0.00% | $720,756.00 |
| ROYAL BANK OF CANADA | 30 Sep, 2025 | 36,222 | 17,922 | 97.93% | $370,000.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 30 Sep, 2025 | 30,001 | -11,316 | -27.39% | $306,610.00 |
| Freestone Capital Holdings, LLC | 30 Sep, 2025 | 25,921 | 0 | 0.00% | $264,913.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 25,357 | 25,357 | 0.00% | $259,149.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 25,000 | 25,000 | 0.00% | $255,500.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 24,895 | -8 | -0.03% | $254,427.00 |
| Nuveen, LLC | 30 Sep, 2025 | 24,497 | 0 | 0.00% | $250,359.00 |